BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Profire Energy, Inc. (Nasdaq – PFIE), Cepton, Inc. (Nasdaq – CPTN), GlycoMimetics, Inc. (Nasdaq – GLYC), ARC Document Solutions, Inc. (NYSE - ARC)

BALA CYNWYD, Pa., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Profire Energy, Inc. (Nasdaq – PFIE)

Under the terms of the agreement, Profire Energy will be acquired by CECO Environmental Corp. (Nasdaq - CECO) (“CECO”) for $2.55 per share in cash. The investigation concerns whether the Profire Energy Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether CECO is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/profire-energy-inc-nasdaq-pfie/,.

Cepton, Inc. (Nasdaq – CPTN)

Under the terms of the Merger Agreement, Cepton will be acquired by KOITO MANUFACTURING CO., LTD. (“Koito”) for $3.17 per share in cash. The investigation concerns whether the Cepton Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Koito is paying fair value to shareholders of the Company. For example, the deal consideration is below the 52-week high of $5.20 for the Company’s shares.

Additional information can be found at https://www.brodskysmith.com/cases/cepton-inc-nasdaq-cptn/.

GlycoMimetics, Inc. (Nasdaq – GLYC)

Under the terms of the agreement, GlycoMimetics will be acquired by Crescent Biopharma, Inc. (“Crescent”). Pre-acquisition GlycoMimetics stockholders are expected to own approximately 3.1% of the combined Company and the pre-acquisition Crescent stockholders (inclusive of those investors participating in the pre-closing financing) are expected to own approximately 96.9% of the company. The investigation concerns whether the GlycoMimetics Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Crescent is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/glycomimetics-inc-nasdaq-glyc/.

ARC Document Solutions, Inc. (NYSE - ARC)

Under the terms of the agreement, Arc will be acquired by TechPrint Holdings, LLC for $3.40 per share in cash. The investigation concerns whether the Arc Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether TechPrint Holdings is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/arc-document-solutions-inc-nyse-arc/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.